Injury/Insult or Disease | Species | Location/Cell type | Timing | Reference |
---|---|---|---|---|
Degenerative Disease | Â | Â | Â | Â |
Alzheimer's Disease | Human | Entorhinal cortex and superior temporal gyrus mRNA; Brain microvessel, Senile plaques, neurofibrillary tangles, CSF protein | Chronic | [48, 80, 82-84] |
Vascular Dementia | Human | CSF protein | Chronic | [84] |
Parkinson's Disease | Human | CSF dopaminergic striatal brain regions, protein | Chronic | [85, 86] |
Amyotrophic Lateral Sclerosis | Human | CSF and serum protein | Chronic | [87] [88] |
Diabetic Neuropathy | Human | Plasma protein | Chronic | [89] |
Acute Insult | Â | Â | Â | Â |
Transient ischemia | Rat | Hippocampus/cerebellar protein; Hippocampal mRNA; Microglial mRNA and protein | 20 min-12 weeks | [90-92] [93, 94] |
Permanent ischemia | Human; rat; Baboon | Increased mRNA in ischemic and penumbral areas | 1–15 days | [95-98] |
Subarachnoid hemorrhage | Human | CSF protein | 1–19 days | [99] |
Posthemorrhagic Hydrocephalus | Human | CSF protein | 1–14 days | [12, 13, 100] |
Spinal cord injury | Human | Spinal cord mRNA | 1–48 h | [101] |
Triethyltin exposure | Mouse | Cortical mRNA | 6 hrs | [102] |
Excitotoxic lesion (NMDA) | Rat | Gray matter surrounding the lesion | Â | [103] |
Status epilepticus | Rat | Hippocampal | 1–3 weeks | [104] |
Kainic acid or deafferentation-induced neurodegeneration | Rat | Reactive microglia, mRNA | Â | [105, 106] |
Spinal cord Contusion | Rat | Spinal cord mRNA | 0.25–10 days | [107] |
Penetrating brain Injury | Rat | Perilesional activated glia, meningeal cells, choroid plexus mRNA and protein | 1–14 days | [108, 109] |
Experimentally induced glaucoma | Monkey | Optic nerve head protein | Chronic | [110] |
Autoimmune Disease | Â | Â | Â | Â |
Multiple Sclerosis | Human | CSF protein; Mononuclear cells from blood and CSF, mRNA; Serum protein during relapses; Peri-lesional hypertrophic astrocytes, protein | Chronic | [111-114] |
Chronic relapsing experimental autoimmune encephalitis | Mouse | Spinal cord mRNA | Chronic | [115] |
Experimental Autoimmune Encephalitis | Rat | Spinal cord T-cell, monocyte, and microglia mRNA | Acute | [116] |
Guillan-Barré Syndrome | Human | Serum and circulating monocyte protein | Plateau phase | [117, 118] |
Experimental Autoimmune Neuritis | Rat | Macrophage, microglia, meningeal cells, and T-cell infiltrates | Acute | [116, 119] |
Infection | Â | Â | Â | Â |
CMV encephalitis | Human/mouse | Astrocyte mRNA | 5-13d after infection | [120] |
ME7 scrapie model | Mouse | Brain mRNA | Â | [121] |
Bacterial Meningitis | Rat Human | CSF cellular mRNA CSF protein Brain mRNA, CSF protein | Acute | [122-124] |
Brain Abscess | Human | Peri-abscess and abscess extracellular matrix protein | Chronic | [125] |